Cargando…
Oxymatrine Inhibits Renal Cell Carcinoma Progression by Suppressing β-Catenin Expression
AIMS: Oxymatrine (OMT) has been identified to possess immunomodulatory, antiinflammatory and anticancer properties. This study aimed to investigate its precise function and the underlying molecular mechanisms in renal cell carcinoma progression. METHODS: The antineoplastic effect of oxymatrine was i...
Autores principales: | Jin, Yinshan, Liu, Jiannan, Liu, Yadong, Liu, Yang, Guo, Guiying, Yu, Shiliang, An, Ruihua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289957/ https://www.ncbi.nlm.nih.gov/pubmed/32581789 http://dx.doi.org/10.3389/fphar.2020.00808 |
Ejemplares similares
-
Cyclovirobuxine inhibits the progression of clear cell renal cell carcinoma by suppressing the IGFBP3-AKT/STAT3/MAPK-Snail signalling pathway
por: Liu, Yadong, et al.
Publicado: (2021) -
Irigenin inhibits glioblastoma progression through suppressing YAP/β-catenin signaling
por: Xu, Jiayun, et al.
Publicado: (2022) -
H3 relaxin protects against calcium oxalate crystal‐induced renal inflammatory pyroptosis
por: Liu, Jiannan, et al.
Publicado: (2020) -
Nintedanib Inhibits Wnt3a-Induced Myofibroblast Activation by Suppressing the Src/β-Catenin Pathway
por: Li, Xiaohe, et al.
Publicado: (2020) -
Oxymatrine Synergistically Enhances Doxorubicin Anticancer Effects in Colorectal Cancer
por: Pan, Di, et al.
Publicado: (2021)